Pain Management Drugs Market
- 2026 年市場規模
- USD 88.4 Bn
- 2033 年預估規模
- USD 113.15 Bn
- 年複合成長率 CAGR
- 3.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Pain Management Drugs Market, By Drug Class (Opioids, NSAIDs, Anticonvulsants, Antidepressants, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Pain management medications are specific drug classes, which have pharmacological actions on pain receptors and work against the pain symptoms. These medications include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, muscle relaxants, and others. These medications can be used for pain management of conditions, as indicated on label and some medications have off-label uses. For instance, anticonvulsants and antidepressants were originally used for the management of epilepsy and depression respectively. However, these medications have shown activity against pain indications and are prescribed for pain management as off-label indication. Moreover, opioids are majorly prescribed for the management of acute as well as chronic pain. This has also resulted in self-medication by patients, resulting in misuse or overdose of opioid containing drug products. Moreover, majority of the drugs have lost patent protection over the years and generic versions of the same are widely available in the market. Commercially available pain management drugs include Fentanyl, Hydromorphone, Oxycodone, Aspirin, Diazepam, and others.
Market Dynamics
The global pain management drugs market is driven by factors such as absence of alternative therapies and high presence of generic drug manufacturers in the market. For instance, in February 2018, according to data published by National Center for Biotechnology Information, increasing number of major drugs such as OxyContin, Opana ER, and Celebrex have lost patent protection due to which generic manufacturers have developed generic version with product variations fostering growth of the pain management drugs market. Continuous requirement of the medication coupled with easy availability is expected to boost the adoption of pain drugs over the forecast period. Proven effectiveness of these medications in improving medical outcomes and increasing prevalence of disorders such as cancer (leading to cancer pain) are fueling growth of the pain management drugs market. However, life threatening side effects associated with these medications, as indicated by the black box warning on the packaging, as well as lack of research and development by major players are expected to hinder growth of the pain management drugs market.
Key features of the study
• This report provides an in-depth analysis of the global pain management drugs market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pain management drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Abbott Laboratories, Purdue Pharma L.P., GlaxoSmithKline Plc, Johnson & Johnson, and F. Hoffmann La Roche Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pain management drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management drugs market
Market Segmentation
• Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
o Opioids
o NSAIDs
o Anticonvulsants
o Antidepressants
o Others
• Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players Insights
o Pfizer, Inc.
o Sanofi S.A.
o Mylan N.V.
o Teva Pharmaceutical Industries Ltd.
o Eily, Lilly, and Company
o Abbott Laboratories
o Purdue Pharma L.P.
o GlaxoSmithKline Plc
o Johnson & Johnson
o F. Hoffmann La Roche Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Global Pain Management Drugs Market, By Drug Class
Global Pain Management Drugs Market, By Distribution Channel
Global Pain Management Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trend
4. Global Pain Management Drugs Market, By Drug Class, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o NSAIDs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Anticonvulsants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
5. Global Pain Management Drugs Market, By Distribution Channel, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
6. Global Pain Management Drugs Market, By Region, 2020 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Pfizer, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Mylan N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Eily, Lilly, and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Purdue Pharma L.P.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o GlaxoSmithKline Plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o F. Hoffmann La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
9. References and Research Methodology
o References
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們